Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYCLOOXYGENASE COX-2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 33 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sumi, T; Ishiko, O; Yoshida, H; Hyun, Y; Nakagawa, E; Hirai, K; Matsumoto, Y; Ogita, S
      Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    2. Deguchi, M; Ishiko, O; Sumi, T; Yoshida, H; Yamamoto, K; Ogita, S
      Expression of angiogenic factors in extrapelvic endometriosis

      ONCOLOGY REPORTS
    3. Ishiko, O; Sumi, T; Yoshida, H; Tokuyama, O; Wakasa, K; Haba, T; Ogita, S
      Cyclooxygenase-2 expression in an adenoid cystic carcinoma of the uterine cervix

      ONCOLOGY REPORTS
    4. Liu, SS; Yin, CS; Shi, YY; Cai, SX; Li, ZL
      MEDV-13 for QSAR studies on the COX-2 inhibition by indomethacin amides and esters

      CHINESE JOURNAL OF CHEMISTRY
    5. Kamijo, T; Sato, T; Nagatomi, Y; Kitamura, T
      Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines

      INTERNATIONAL JOURNAL OF UROLOGY
    6. Sumitani, H; Kamijo, R; Toyoshima, T; Nakanishi, Y; Takizawa, K; Hatori, M; Nagumo, M
      Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E-2 production

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    7. Gaffney, DK; Holden, J; Zempolich, K; Murphy, KJ; Dicker, AP; Dodson, M
      Elevated COX-2 expression in cervical carcinoma - Reduced cause-specific survival and pelvic control

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    8. Komers, R; Anderson, S; Epstein, M
      Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors

      AMERICAN JOURNAL OF KIDNEY DISEASES
    9. Barton, CC; Barton, EX; Ganey, PE; Kunkel, SL; Roth, RA
      Bacterial lipopolysaccharide enhances aflatoxin B-1 hepatotoxicity in ratsby a mechanism that depends on tumor necrosis factor alpha

      HEPATOLOGY
    10. Dannhardt, G; Kiefer, W
      Cyclooxygenase inhibitors - current status and future prospects

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    11. Corasaniti, MT; Maccarrone, M; Nistico, R; Malorni, W; Rotiroti, D; Bagetta, G
      Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo

      JOURNAL OF NEUROCHEMISTRY
    12. Crofford, LJ
      Clinical experience with specific COX-2 inhibitors in arthritis

      CURRENT PHARMACEUTICAL DESIGN
    13. Song, YG; Kwon, HM; Kim, JM; Hong, BK; Kim, DS; Huh, AJ; Chang, KH; Kim, HY; Kang, TS; Lee, BK; Choi, DH; Jang, YS; Kim, HS
      Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: A possible pathogenetic mechanism of atherosclerosis induced Chlamydia pneumoniae

      YONSEI MEDICAL JOURNAL
    14. Perazella, MA; Eras, J
      Are selective COX-2 inhibitors nephrotoxic?

      AMERICAN JOURNAL OF KIDNEY DISEASES
    15. Ryu, HS; Chang, KH; Yang, HW; Kim, MS; Kwon, HC; Oh, KS
      High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion

      GYNECOLOGIC ONCOLOGY
    16. Davidson, ME; Lang, RJ
      Effects of selective inhibitors of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2) on the spontaneous myogenic contractions in the upper urinary tract of the guinea-pig and rat

      BRITISH JOURNAL OF PHARMACOLOGY
    17. Moon, TC; Murakami, M; Kudo, I; Son, KH; Kim, HP; Kang, SS; Chang, HW
      A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa

      INFLAMMATION RESEARCH
    18. Ochiai, M; Oguri, T; Isobe, T; Ishioka, S; Yamakido, M
      Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues andnon-small cell lung cancers

      JAPANESE JOURNAL OF CANCER RESEARCH
    19. Ehrich, EW; Schnitzer, TJ; McIlwain, H; Levy, R; Wolfe, F; Weisman, M; Zeng, Q; Morrison, B; Bolognese, J; Seidenberg, B; Gertz, BJ
      Effect of specific COX-2 inhibition in osteoarthritis of the knee: A 6 week double blind, placebo controlled pilot study of rofecoxib

      JOURNAL OF RHEUMATOLOGY
    20. Gierse, JK; Koboldt, CM; Walker, MC; Seibert, K; Isakson, PC
      Kinetic basis for selective inhibition of cyclo-oxygenases

      BIOCHEMICAL JOURNAL
    21. Chiarugi, V; Magnelli, L; Chiarugi, A; Gallo, O
      Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkB-dependent inducible nitric oxide synthase and cyclooxygenase-2

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    22. HARADA Y; KAWAMURA M; HATANAKA K; SAITO M; OGINO M; OHNO T; OGINO K; YANG QS
      DIFFERING PROFILES OF PROSTAGLANDIN FORMATION INHIBITION BETWEEN SELECTIVE PROSTAGLANDIN-H SYNTHASE-2 INHIBITORS AND CONVENTIONAL NSAIDS ININFLAMMATORY AND NONINFLAMMATORY SITES OF THE RAT

      PROSTAGLANDINS & OTHER LIPID MEDIATORS
    23. PAIRET M
      PHARMACOLOGICAL CHARACTERIZATION OF MELOXICAM

      Journal of clinical rheumatology
    24. VANE JR; BOTTING RM
      ANTIINFLAMMATORY DRUGS AND THEIR MECHANISM OF ACTION

      Inflammation research
    25. Kase, Y; Saitoh, K; Ishige, A; Komatsu, Y
      Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    26. STICHTENOTH DO; ZEIDLER H; FROLICH JC
      NEW NONSTEROIDAL ANTIINFLAMMATORY DRUGS - SELECTIVE INHIBITORS OF THEINDUCIBLE CYCLOOXYGENASE

      Medizinische Klinik
    27. NOREEN Y; SERRANO G; PERERA P; BOHLIN L
      FLAVAN-3-OLS ISOLATED FROM SOME MEDICINAL-PLANTS INHIBITING COX-1 ANDCOX-2 CATALYZED PROSTAGLANDIN BIOSYNTHESIS

      Planta medica
    28. HEISE G; GRABENSEE B; SCHROR K; HEERING P
      DIFFERENT ACTIONS OF THE CYCLOOXYGENASE-2 SELECTIVE INHIBITOR FLOSULIDE IN RATS WITH PASSIVE HEYMANN NEPHRITIS

      Nephron
    29. KRISHNAN K; RUFFIN MT; BRENNER DE
      COLON-CANCER CHEMOPREVENTION - CLINICAL DEVELOPMENT OF ASPIRIN AS A CHEMOPREVENTIVE AGENT

      Journal of cellular biochemistry
    30. LUKIW WJ; BAZAN NG
      CYCLOOXYGENASE-2 RNA MESSAGE ABUNDANCE, STABILITY, AND HYPERVARIABILITY IN SPORADIC ALZHEIMER NEOCORTEX

      Journal of neuroscience research
    31. OSUKA K; SUZUKI Y; WATANABE Y; DOGAN A; TAKAYASU M; SHIBUYA M; YOSHIDA J
      VASODILATOR EFFECTS ON CANINE BASILAR ARTERY INDUCED BY INTRACISTERNAL INTERLEUKIN-1-BETA

      Journal of cerebral blood flow and metabolism
    32. CHULADA PC; LANGENBACH R
      DIFFERENTIAL INHIBITION OF MURINE PROSTAGLANDIN SYNTHASE-1 AND SYNTHASE-2 BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS USING EXOGENOUS AND ENDOGENOUS SOURCES OF ARACHIDONIC-ACID

      The Journal of pharmacology and experimental therapeutics
    33. MAJIMA M; ISONO M; IKEDA Y; HAYASHI I; HATANAKA K; HARADA Y; KATSUMATA O; YAMASHINA S; KATORI M; YAMAMOTO S
      SIGNIFICANT ROLES OF INDUCIBLE CYCLOOXYGENASE (COX)-2 IN ANGIOGENESISIN RAT SPONGE IMPLANTS

      Japanese Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 10:08:33